Company / Interest Expense per Share
Harmony Biosciences Holdings, Inc. Interest Expense per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.26
FY2025
5-year range
$0.13 / $0.40
FY2021-FY2025
Trend
-16.8%
vs FY2024
Sector context
#17 of 43
Health Care
What the data says
At $0.26, Harmony Biosciences Holdings, Inc.'s interest expense per share ranks #27 of 43 in the Health Care sector. Improved from $0.40 to $0.26 over the past 2 years.
Based on SEC 10-K filings.
0.26 in FY2025 with a 3-year CAGR of -7.1%.
Improved from $0.40 to $0.26 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -7.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#27 of 43 in Health CareTop 60% of 43This company $0.26 Sector average $9.80
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share decreased 16.8% year-over-year.
- Ranks #17 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2019.
- Lowest interest expense per share in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.26 | -16.8% |
| FY2024 | $0.31 | -22.7% |
| FY2023 | $0.40 | +24.7% |
| FY2022 | $0.32 | +146.9% |
| FY2021 | $0.13 | - |
| FY2020 | - | - |
| FY2019 | $0.95 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026